NKTX Stock Analysis: Buy, Sell, or Hold?

NKTX - Nkarta, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.22
-0.21 (-8.64%) ▼
WAIT
LOW Confidence
Protect Your NKTX Gains
Last Updated: January 30, 2026
Earnings: Mar 25, 2026
Smart Money Accumulation

NKTX is down 10.8% this week, but smart money is accumulating calls. Top strike: $2.5 2026-03-20 with 16 OI. Call ratio: 100% View Scanner →

Strength: 10.0/10

Get Alerted When NKTX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NKTX is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: NKTX is currently trading at $2.22, which is considered slightly high relative to its 30-day fair value range of $1.85 to $2.33.

Technical Outlook: Technically, NKTX is showing sideways momentum. Immediate support is located at $1.93, while resistance sits at $2.60. Short-term momentum is weak, with the stock down 8.6% recently.

Market Sentiment: NKTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.25 (+406.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $1.85 - $2.33
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 73.7%

Protect Your Profits

Holding NKTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-8.6%)
  • BULLISH: Trading 406.8% below Wall St target ($11.25)
  • WARNING: Recommendation downgraded due to -10.8% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $1.85 - $2.33
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $1.93
Resistance Level $2.60
Current Trend Sideways

Fundamental Context

Forward P/E (Next Year Est.) -1.69
Wall Street Target $11.25 (+406.8%)
Last updated: February 01, 2026 10:00 AM ET
Data refreshes hourly during market hours. Next update: 11:00 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$112 52 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$93 59 HOLD
RNA
Avidity Biosciences Inc
STRONG BUY
15 analysts
$75 62 BUY
GPCR
Structure Therapeutics I…
STRONG BUY
14 analysts
$108 56 HOLD
APLS
Apellis Pharmaceuticals …
BUY
22 analysts
$34 51 HOLD

Advanced NKTX Option Strategies

Professional options setups generated by AI based on today's NKTX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NKTX

NKTX Technical Chart NKTX Price Prediction NKTX Earnings Date NKTX Investment Advisor NKTX Fair Price Analyzer NKTX Options Advisor NKTX Options Chain NKTX Options Analysis NKTX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals